According to a report from Focustaiwan on June 20th, the police in New Taipei City, Taiwan seized over 4,000 e-cigarette replacement pods in a drug raid last week.
According to a press release from the agency, this drug bust was carried out based on an anonymous tip, which reported that a resident in Sanchong District had stockpiled a large number of e-cigarette pods at home. At 5 pm on June 13, the police raided the residence of a 24-year-old man surnamed Dong and seized thousands of replacement pods in various flavors.
According to the police, the man purchased these pods online and sold them on social media platforms, which was his main source of income. In a raid, authorities seized a total of 4,189 pods, estimated to have a market value of 1 million New Taiwan Dollars (approximately $30,868 USD).
In the testing, it was found that these pods contained "Methoxy Ma Huang Tang", a synthetic stimulant classified as a Class III drug in Taiwan, China.
Currently, the man has been arrested and transferred to the New Taipei District Prosecutors Office in Taiwan for investigation on suspicion of violating Taiwan's Harm Prevention Act.
The "Tobacco Hazards Prevention Act" in Taiwan, China prohibits the production, sale, import, supply, and advertising of "imitation tobacco products," including electronic nicotine and non-nicotine delivery systems such as e-cigarettes, pods, and vape pens.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
